Atsuko Takagi

479 total citations
32 papers, 355 citations indexed

About

Atsuko Takagi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Atsuko Takagi has authored 32 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Atsuko Takagi's work include Lipid metabolism and disorders (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and biosynthesis (6 papers). Atsuko Takagi is often cited by papers focused on Lipid metabolism and disorders (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and biosynthesis (6 papers). Atsuko Takagi collaborates with scholars based in Japan. Atsuko Takagi's co-authors include Yasuyuki Ikeda, Yasuji Oshima, Satoshi Harashima, Akira Yamamoto, Mariko Harada‐Shiba, Shinji Yokoyama, Shigeori Takenaka, Kenichi Yamashita, Hiroki Kondo and Makoto Takagi and has published in prestigious journals such as Nucleic Acids Research, Circulation Research and Molecular and Cellular Biology.

In The Last Decade

Atsuko Takagi

31 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsuko Takagi Japan 10 192 98 86 84 56 32 355
Denise Lee Singapore 8 232 1.2× 66 0.7× 41 0.5× 69 0.8× 31 0.6× 23 430
Ziye Liu China 9 139 0.7× 112 1.1× 47 0.5× 74 0.9× 15 0.3× 19 333
Cafer Ozdemir United States 9 205 1.1× 48 0.5× 35 0.4× 37 0.4× 23 0.4× 11 400
Joan M. Augustyn United States 10 126 0.7× 67 0.7× 105 1.2× 29 0.3× 64 1.1× 20 380
Toru Yanagimoto Japan 9 234 1.2× 21 0.2× 20 0.2× 32 0.4× 45 0.8× 12 408
Paulette M. Gaynor United States 12 325 1.7× 23 0.2× 207 2.4× 71 0.8× 24 0.4× 12 585
Hongfang Lu Canada 6 196 1.0× 17 0.2× 201 2.3× 67 0.8× 94 1.7× 7 455
Ogooluwa Ojelabi United States 10 232 1.2× 33 0.3× 28 0.3× 24 0.3× 31 0.6× 13 402
Haili Cheng China 11 233 1.2× 57 0.6× 11 0.1× 50 0.6× 17 0.3× 17 353
Xi Zhou China 6 159 0.8× 24 0.2× 76 0.9× 12 0.1× 19 0.3× 27 339

Countries citing papers authored by Atsuko Takagi

Since Specialization
Citations

This map shows the geographic impact of Atsuko Takagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Takagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Takagi more than expected).

Fields of papers citing papers by Atsuko Takagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Takagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Takagi. The network helps show where Atsuko Takagi may publish in the future.

Co-authorship network of co-authors of Atsuko Takagi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Takagi. A scholar is included among the top collaborators of Atsuko Takagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Takagi. Atsuko Takagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirano, Ken‐ichi, Masahiro Higashi, Hideyuki Miyauchi, et al.. (2019). Increased Washout of <sup>123</sup>I-BMIPP in Triglyceride Deposit Cardiomyovasculopathy (TGCV) with Severe Coronary Stenosis. 5(1). 47–49. 2 indexed citations
2.
3.
Takagi, Atsuko, Yasuyuki Ikeda, Kunihisa Kobayashi, et al.. (2017). Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy. Biochemical and Biophysical Research Communications. 495(1). 646–651. 8 indexed citations
4.
Nishimura, Makoto, et al.. (2006). Change in Immunoreactive Human Hepatic Triglyceride Lipase (HTGL) Mass and the Shelf‐Life of the HTGL ELISA Kit in Long‐Term Storage. Journal of Immunoassay and Immunochemistry. 27(1). 89–102. 1 indexed citations
5.
Nojima, Takahiko, Kenichi Yamashita, Atsuko Takagi, et al.. (2005). Genotyping of the Human Lipoprotein Lipase Gene by Ferrocenylnaphthalene Diimide-based Electrochemical Hybridization Assay. Analytical Sciences. 21(12). 1437–1441. 5 indexed citations
6.
Tamasawa, Naoki, Jun Matsui, Hiroshi Murakami, et al.. (2005). Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia. Diabetes Research and Clinical Practice. 72(1). 6–11. 5 indexed citations
7.
Harada‐Shiba, Mariko, Atsuko Takagi, Yoshihiro Miyamoto, et al.. (2003). Clinical Features and Genetic Analysis of Autosomal Recessive Hypercholesterolemia. The Journal of Clinical Endocrinology & Metabolism. 88(6). 2541–2547. 45 indexed citations
8.
Nojima, Takahiko, Kenichi Yamashita, Atsuko Takagi, et al.. (2003). Direct Detection of Single Nucleotide Polymorphism (SNP) with Genomic DNA by the Ferrocenylnaphthalene Diimide-based Electrochemical Hybridization Assay (FND-EHA). Analytical Sciences. 19(1). 79–83. 12 indexed citations
9.
Ikeda, Yasuyuki, et al.. (2002). A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency. Clinica Chimica Acta. 316(1-2). 179–185. 2 indexed citations
10.
Takagi, Atsuko, Yasuyuki Ikeda, Eiji Takeda, & Akira Yamamoto. (2000). A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1502(3). 433–446. 9 indexed citations
12.
Mori, Atsuo, Atsuko Takagi, Yasuyuki Ikeda, & Akira Yamamoto. (2000). Improved method for direct DNA sequencing of the human lipoprotein lipase gene using an auto DNA sequencer. Clinical Biochemistry. 33(4). 323–327.
13.
Kimurâ, Hiroshi, Yasuhiko Ohkaru, Hiroo Ishii, et al.. (1999). Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma. Clinical Biochemistry. 32(1). 15–23. 8 indexed citations
14.
Tamasawa, Naoki, Hiroshi Murakami, Tomio Onuma, et al.. (1998). Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy. Journal of Internal Medicine. 243(4). 317–321. 31 indexed citations
15.
Mori, Atsuo, Atsuko Takagi, Yasuyuki Ikeda, & Akira Yamamoto. (1997). Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene. Clinical Biochemistry. 30(4). 315–324. 8 indexed citations
17.
Mori, Atsuo, et al.. (1996). AnAvaII polymorphism in exon 5 of the human hepatic triglyceride lipase gene. Molecular and Cellular Probes. 10(4). 309–311. 4 indexed citations
18.
Takagi, Atsuko, Yasuyuki Ikeda, & Akira Yamamoto. (1990). DNA sequence of lipoprotein lipase cDNA cloned from human monocytic leukemia THP-1 cells. Nucleic Acids Research. 18(21). 6436–6436. 4 indexed citations
19.
Takagi, Atsuko, Satoshi Harashima, & Yasuji Oshima. (1985). Hybridization and Polyploidization of Saccharomyces cerevisiae Strains by Transformation-Associated Cell Fusion. Applied and Environmental Microbiology. 49(1). 244–246. 11 indexed citations
20.
Takagi, Atsuko, et al.. (1985). Constant copy numbers of plasmids inSaccharomyces cerevisiae hosts with different ploidies. Applied Microbiology and Biotechnology. 23(2). 123–129. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026